The prevalence of T2DM is predicted to rise by 46% globally by 2045, suggesting that this issue becomes even more ominous as time progresses
Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus
10.1002/jsfa.10192 [DOI] [PubMed] [Google Scholar] 102.Culetu A, Hritier J, Andlauer W
Regular blood glucose monitoring is important, particularly when making changes to your treatment regimen
The tricky part is that early warning signs can look a lot like typical GLP-1 side effects, so it's easy to write off symptoms that actually deserve attention
Cross-trial comparisons suggest CagriSema may offer the highest pharmacological weight loss achieved to date: Note: Direct cross-trial comparisons have limitations due to differences in populations, trial designs, and durations